/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Neoscope

Topic

Latest Stories

Exaggerated Claims
5.12.20, 12:45 PM EDT on neoscope
CityMD Wrongly Told 15,000 Patients They Were Immune to COVID-19
Dire Warning
5.12.20, 11:50 AM EDT on neoscope
Fauci: Reopening Too Soon Could Lead to "Suffering and Death"
Big Push
5.12.20, 11:30 AM EDT on neoscope
After Six New Cases, Wuhan Plans to Test All 11 Million Residents
Resurgence
5.11.20, 3:59 PM EDT on neoscope
There's a Resurgence of Coronavirus Cases in China
Under The Counter
5.9.20, 10:20 AM EDT on neoscope
Darknet Marketplaces Are Full of COVID-19 Tests and Medicine
Everyone Gets One!
5.8.20, 9:15 AM EDT on neoscope
Doctors Are Cloning COVID Patients' Antibodies For New Treatment
Lottery System
5.7.20, 1:09 PM EDT on neoscope
Bioethicist: COVID-19 "Immunity Passports" Are a Bad Idea
There He Goes Again
5.7.20, 12:01 PM EDT on neoscope
Trump: Wearing Mask Would "Send the Wrong Message"
Silencing Experts
5.7.20, 10:59 AM EDT on neoscope
White House Secretly Buried CDC Guidelines on Reopening Country
Early Transmission
5.6.20, 2:24 PM EDT on neoscope
Scientists: COVID-19 Spread Globally for Months Before We Noticed
Contagion
5.5.20, 4:35 PM EDT on neoscope
Scientists Warn of More Contagious Strain of the Coronavirus
Mass Testing
5.5.20, 3:58 PM EDT on neoscope
MIT Invents $6 COVID-19 Test Using CRISPR
  • Previous
  • 1
  • ...
  • 174
  • 175
  • 176
  • ...
  • 217
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.